Group (No.) | Sex (M/F) | Age (yr) | Disease Duration (yr) | HY | HY | UPDRS | UPDRS | MMSE |
---|---|---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | (ON) | (OFF) | (ON) | (OFF) | (ON) | ||
PD (12) | 5/7 | 62.1 (12.7) | 5.8 (4.5) | 1.8 (0.4)* | 1.9 (0.6) | 43 (13.8)a | 53.3 (22.1) | 28.2 |
Controls (13) | 8/5 | 58.0 (7.3) | N/A | N/A | N/A | N/A | N/A | 28.8 |
Note:—NA indicates data not available; M, male; F, female; HY, Hoehn and Yahr clinical staging; UPDRS, Unified Parkinson Disease Rating Scale; MMSE, Mini-Mental State Examination; ON, taking medication as normal; OFF, cessation of medication.
* Levodopa equivalent dosage = 585.2 ± 509.8 mg.